Clinical trial
Multi-center Clinical Study on Early Screening and Treatment of Hyperbilirubinemia of Term and Late-preterm Neonates
NCT03824990 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center Clinical Study on Early Screening and Treatment of Hyperbilirubinemia of Term and Late-preterm Neonates
- Lead sponsor
- Nanjing Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2018
- Completion date
- October 15, 2021
- Enrollment
- 20,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyperbilirubinemia, neonatal, quality improvement